{"id":7469,"date":"2018-04-26T18:21:39","date_gmt":"2018-04-26T22:21:39","guid":{"rendered":"http:\/\/lifeinsurance-orleans.ca\/Life-Insurance-Blog\/?guid=cca09d96f4079d5a6a38e18a0c864471"},"modified":"2018-04-26T18:21:39","modified_gmt":"2018-04-26T22:21:39","slug":"pbo-pegs-cost-of-extended-drug-patents-at-270m-a-year-for-feds-392m-for-cdns","status":"publish","type":"post","link":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/2018\/04\/26\/pbo-pegs-cost-of-extended-drug-patents-at-270m-a-year-for-feds-392m-for-cdns\/","title":{"rendered":"PBO pegs cost of extended drug patents at $270M a year for feds, $392M for Cdns"},"content":{"rendered":"<p>OTTAWA &#8212; An extension of drug patent protections in the Canada-EU free trade deal could end up costing Canadians an estimated $392 million a year, and federal coffers up to $270 million more annually, says a new report from the parliamentary budget officer.<\/p>\n<p>The report released Thursday sets out to put a price tag on a central &#8212; and controversial &#8212; element of the Comprehensive Economic and Trade Agreement, or CETA, that went into effect last September.<\/p>\n<p>Federal legislation that enacted the deal added two years to the existing 20-year patent protections for drugs containing new medicinal ingredients, which accounted for about one-third of all patented drugs sold in 2015.<\/p>\n<p>As a result, drug companies now enjoy a 22-year period of market exclusivity for eligible drugs before cheaper, generic versions can be produced and sold. Canadians spent $15.2 billion on patented drugs in 2015, says the review board responsible for monitoring patented drug prices.<\/p>\n<p>In the interim, the cost of pharmaceuticals will only continue to go up, said Philip Bagnoli, a senior economist who helped compile the report.<\/p>\n<p>&#8220;The higher drug prices are, which will go up in the future, the larger the gap is going to be between the patented price and the non-patented price,&#8221; Bagnoli said.<\/p>\n<p>&#8220;Drug companies will tell you that developing drugs is getting more and more expensive over time.&#8221;<\/p>\n<p>The estimated figures &#8212; based on 2015 data &#8212; are meant to provide an &#8220;illustrative analysis&#8221; to study the potential impact of the two-year extension, the report says. None of the drugs on the market were eligible for the extension when it was granted last year.<\/p>\n<p>The PBO&#8217;s cost figures don&#8217;t include the spending that would come from institutions like hospitals and long-term care facilities, which would cause the estimates to rise significantly &#8212; to more than $500 million a year in the case of consumers.<\/p>\n<p>Most of the additional government expense would go toward provincial public drug programs, the report says. Those costs, estimated at around $214 million a year, are borne by Ottawa under a commitment the former Conservative government made with the provinces in 2013.<\/p>\n<p>When the federal government first studied Canada&#8217;s patent laws, it was with the understanding that drug manufacturers would increase research and development conducted within the country, Bagnoli said.<\/p>\n<p>&#8220;Drug companies promised us they would do a lot more research in Canada in exchange for patent protection,&#8221; he said. &#8220;They haven&#8217;t lived up to that.&#8221;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>OTTAWA &mdash; An extension of drug patent protections in the Canada-EU free trade deal could end up costing Canadians an estimated $392 million a year, and federal coffers up to $270 million more annually, says a new report from the parliamentary budget officer. The report released Thursday sets out to put a price tag on [&hellip;]<\/p>\n","protected":false},"author":578,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[],"tags":[],"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/posts\/7469"}],"collection":[{"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/users\/578"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/comments?post=7469"}],"version-history":[{"count":1,"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/posts\/7469\/revisions"}],"predecessor-version":[{"id":7470,"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/posts\/7469\/revisions\/7470"}],"wp:attachment":[{"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/media?parent=7469"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/categories?post=7469"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/tags?post=7469"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}